Latin America Genome Editing Market Size & Outlook
Latin America genome editing market, 2018-2030 (US$M)
Related Markets
Latin America genome editing market highlights
- The Latin America genome editing market generated a revenue of USD 481.3 million in 2023.
- The market is expected to grow at a CAGR of 15.7% from 2024 to 2030.
- In terms of segment, (crispr)/cas9 was the largest revenue generating technology in 2023.
- (CRISPR)/Cas9 is the most lucrative technology segment registering the fastest growth during the forecast period.
- Country-wise, Brazil is expected to register the highest CAGR from 2024 to 2030.
Latin America data book summary
| Market revenue in 2023 | USD 481.3 million |
| Market revenue in 2030 | USD 1,337.2 million |
| Growth rate | 15.7% (CAGR from 2023 to 2030) |
| Largest segment | (crispr)/cas9 |
| Fastest growing segment | (CRISPR)/Cas9 |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | (CRISPR)/Cas9, TALENs/MegaTALs, ZFN, Meganuclease |
| Key market players worldwide | Merck KGaA, Cibus Inc Ordinary Shares - Class A, Recombinetics, Sangamo Therapeutics Inc, Editas Medicine Inc, Precision BioSciences Inc, CRISPR Therapeutics AG, Intellia Therapeutics Inc, Caribou Biosciences Inc Ordinary Shares, Cellectis SA, AstraZeneca PLC, Takara Bio Inc, Horizon Discovery, Danaher Corp, Genscript Biotech Corp Class H, New England Biolabs, Origene Technologies, Bluebird bio Inc, Lonza Group Ltd, Thermo Fisher Scientific Inc |
Other key industry trends
- In terms of revenue, Latin America region accounted for 6.0% of the global genome editing market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 3,743.8 million by 2030.
(crispr)/cas9 was the largest segment with a revenue share of 45.11% in 2023. Horizon Databook has segmented the Latin America genome editing market based on (crispr)/cas9, talens/megatals, zfn, meganuclease covering the revenue growth of each sub-segment from 2018 to 2030.
Brazilian farmers are adopting advanced genome editing technologies to develop new crops that benefit farmers and consumers. For instance, researchers at the University of Sao & Federal University of Vicosa in Brazil entered into a partnership with researchers from Germany and the U.S. They developed a new tomato crop from wild plants, using CRISPR-Cas9 genome editing technology.
This new variety yields 10 times the number of fruits compared to the wild type. In addition, fruits are three times bigger in size. Furthermore, increasing usage of CRISPR genome editing technology for multiple research projects is expected to fuel market growth over the forecast period. In Brazil, CRISPR technology is used for several applications, ranging from drug screening to functional genomics.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genome Editing Market Scope
Genome Editing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America genome editing market size, by country, 2018-2030 (US$M)
Latin America Genome Editing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
